BG
ANIK icon

BlackRock Group’s Anika Therapeutics ANIK Stock Holding History

BlackRock Group’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.61M Buy
32,877
+9,608
+41% +$444K ﹤0.01% 1905
2016
Q3 		$1.11M Buy
23,269
+1,963
+9% +$97K ﹤0.01% 1974
2016
Q2 		$1.14M Buy
21,306
+977
+5% +$46K ﹤0.01% 1903
2016
Q1 		$909K Buy
20,329
+2,881
+17% +$117K ﹤0.01% 1981
2015
Q4 		$666K Sell
17,448
-2,354
-12% -$90K ﹤0.01% 2087
2015
Q3 		$630K Buy
19,802
+1,209
+7% +$42.2K ﹤0.01% 2107
2015
Q2 		$614K Buy
18,593
+2,069
+13% +$73.8K ﹤0.01% 2185
2015
Q1 		$680K Sell
16,524
-274
-2% -$11.1K ﹤0.01% 2064
2014
Q4 		$685K Sell
16,798
-12,443
-43% -$486K ﹤0.01% 2101
2014
Q3 		$1.07M Sell
29,241
-3,996
-12% -$173K ﹤0.01% 1739
2014
Q2 		$1.54M Buy
33,237
+25,375
+323% +$1.13M ﹤0.01% 1598
2014
Q1 		$323K Sell
7,862
-1,533
-16% -$57K ﹤0.01% 2354
2013
Q4 		$359K Buy
9,395
+3,089
+49% +$95.3K ﹤0.01% 2301
2013
Q3 		$151K Buy
+6,306
New +$142K ﹤0.01% 2541

Other funds holding ANIK

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Group's ANIK Position: Q4 2016 in Review

BlackRock Group increased its Anika Therapeutics (ANIK) stake by 41% in Q4 2016, buying an estimated $444K and bringing the position to 32,877 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

BlackRock Group first reported a position in ANIK in Q3 2013 and has held it in 14 quarters since. 158 funds tracked by Wall St. Rank hold ANIK as of Q4 2016.

  • BlackRock Group held 32,877 shares of Anika Therapeutics worth $1.61M as of Q4 2016.
  • BlackRock Group bought 9,608 Anika Therapeutics shares in Q4 2016, an estimated $444K.
  • Anika Therapeutics made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1905 holding.
  • BlackRock Group first reported a position in Anika Therapeutics in Q3 2013 and has held it in 14 quarters since.
  • 158 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.